HEPATITIS B, CHRONIC
Clinical trials for HEPATITIS B, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS B, CHRONIC trials appear
Sign up with your email to follow new studies for HEPATITIS B, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental vaccine aims to tame silent hepatitis b infection
Disease control TerminatedThis study tested whether a new vaccine called HepTcell could help the body's immune system fight chronic hepatitis B in people who weren't taking medication for it. Researchers gave the vaccine or a placebo to 87 adults with inactive hepatitis B to see if it reduced virus levels…
Matched conditions: HEPATITIS B, CHRONIC
Phase: PHASE2 • Sponsor: Altimmune, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
GSK tests new vaccine combo to fight chronic hepatitis b
Disease control TerminatedThis early-stage study tested a new combination of therapeutic vaccines in adults with chronic Hepatitis B who were already taking antiviral pills. The main goals were to check the safety of the vaccines and see if they could help the body's immune system fight the virus and redu…
Matched conditions: HEPATITIS B, CHRONIC
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
New shot aims to knock down stubborn hepatitis b virus
Disease control TerminatedThis study tested whether adding a new investigational drug called ARC-520 to the standard Hepatitis B medication entecavir could better control the virus. It involved 58 adults with chronic Hepatitis B and aimed to see if the combination could safely and significantly reduce lev…
Matched conditions: HEPATITIS B, CHRONIC
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC